BGY
BMEZ
BDJ
BOE
CII

Christopher Accettella

CIK: 0001513197

Christopher Accettella's purchase track record

How the stock did after each of Christopher Accettella's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 4 since February 4, 2022
Stock higher 6 months later
50%
3 months: 75%
Median 6-month return
+0.4%
3 months: +4.0%
Beat the S&P 500
0%
median -9.9% vs. index
PurchaseStockAmount3 months6 months
1/11/2024BMEZ$18K+3.5%+6.5%
3/17/2023BMEZ$5K+9.3%-1.5%
3/8/2023BMEZ$5K+4.5%+2.3%
2/4/2022BMEZ$39K-20.1%-15.0%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

this person other insiders at BGY

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

BMEZ Q2 2026 Commentary Released on SeekingAlpha. A Q2 2026 commentary for BlackRock Health Sciences Term Trust was published on SeekingAlpha. The report reviews the trust’s recent performance and outlook. This update adds fresh information for investors as the share trades near its 52‑week low.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock Closed-End Funds Release Estimated Distribution Sources. BlackRock has announced the estimated sources of distributions for several of its closed‑end funds, including BDJ. The disclosure gives investors a clearer view of where the fund’s future payouts will come from. This may influence how investors assess the fund’s income potential. The update is a routine disclosure that helps keep the market informed about the fund’s distribution strategy.

this person other insiders at BDJ

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock Closed‑End Funds Announce Distribution Sources. BlackRock has announced the estimated sources of distributions for several of its closed‑end funds. CII, a BlackRock closed‑end fund, is included in this update, giving investors clearer insight into where the fund’s income will come from. The announcement does not change the fund’s current dividend yield of 6.83% or its price range, but it may help investors assess future cash flow.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock CEFs Announce Estimated Sources of Distributions. BlackRock has announced the estimated sources of distributions for certain closed-end funds, including the Science and Technology Term Trust. This disclosure provides transparency on how payouts are generated, which is a key consideration for income-focused holders. The fund's low trailing P/E of 1.9 suggests a valuation profile that may be sensitive to such distribution details.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

BME Cited In Healthcare Fund Yield Discussion. Blackrock Health Sciences Trust (BME) was mentioned in a SeekingAlpha article discussing healthcare funds with yields over 10%. The piece highlights the fund's income potential, which may draw attention from investors seeking steady returns in the sector. This mention places BME in the context of high-yield options, though the article does not provide specific new financial data for the trust.

this person other insiders at BME

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Bond Market Turmoil Could Impact BGR. Bond market volatility may create challenges for BGR, a tech‑heavy fund. The article notes that rising bond yields could pressure the fund’s performance. BGR’s current RSI is neutral and it trades near the middle of its 52‑week range. Stakeholders should watch how bond market conditions evolve.

this person other insiders at BGR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Insiders Buy Into Bluerock Private Real Estate Fund. Recent reports indicate that insiders have purchased shares in the Bluerock Private Real Estate Fund, a move often interpreted as a sign of internal confidence in the fund's outlook. This development provides context for BTX, which is currently trading near its support level with a low RSI, suggesting the stock may be in a corrective phase despite the positive insider activity.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BCX noted as potential income play after 3.6% Social Security increase. The government announced a 3.6% increase in Social Security benefits. This boost to retirement income may lead income‑focused investors to look at dividend‑paying stocks such as BCX, which offers a 6.91% yield. The company's low trailing P/E of 4.7 also suggests value appeal. The news does not directly involve BCX but could influence demand for its shares.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BST seen as portfolio option after 3.6% Social Security rise. The government announced a 3.6% increase in Social Security benefits. This change may affect investors who focus on income‑generating assets, and some may look at trusts like BST as part of a diversified portfolio. BST currently trades with a low trailing P/E of 2.7 and is near the lower end of its 52‑week range, which adds valuation context to the discussion.

Transaction History

BGY▲ Buy—
BGY▼ Sell$9K
BMEZ▲ Buy—
BMEZ▼ Sell$3K
BDJ▲ Buy—
BDJ▼ Sell$6K
BOE▲ Buy—
BOE▼ Sell$9K
CII▲ Buy—
CII▼ Sell$7K
BSTZ▲ Buy—
BSTZ▼ Sell$6K
BME▲ Buy—
BME▼ Sell$8K
BGR▲ Buy—
BGR▼ Sell$10K
BTX▲ Buy—
BTX▼ Sell$3K
BCX▲ Buy—
BCX▼ Sell$8K
BST▲ Buy—
BST▼ Sell$6K
BUI▲ Buy—
BUI▼ Sell$9K
BOE▼ Sell$9K
BGY▲ Buy—
BGY▼ Sell$9K
BDJ▲ Buy—
BDJ▼ Sell$9K
BOE▲ Buy—
CII▲ Buy—
CII▼ Sell$10K
BSTZ▲ Buy—
BSTZ▼ Sell$4K
BME▲ Buy—
BME▼ Sell$8K
BGR▼ Sell$12K
BGR▲ Buy—
BCX▲ Buy—
BCX▼ Sell$9K
BST▲ Buy—
BST▼ Sell$8K
BUI▲ Buy—
BUI▼ Sell$8K
BMEZ▲ Buy$18K
BMEZ▲ Buy$5K
BMEZ▲ Buy$5K
BOE▲ Buy—
BOE▼ Sell$12K
BGY▲ Buy—
BGY▼ Sell$12K
BDJ▲ Buy—
BDJ▼ Sell$10K
BME▲ Buy—
BME▼ Sell$9K
CII▲ Buy—
CII▼ Sell$7K
BGR▲ Buy—
BGR▼ Sell$13K
BSTZ▲ Buy—
BSTZ▼ Sell$4K
BCX▲ Buy—
BCX▼ Sell$12K
BST▲ Buy—
BUI▲ Buy—
BUI▼ Sell$8K
BST▼ Sell$7K
BMEZ▲ Buy$39K
BOE▲ Buy—
BOE▼ Sell$13K
BDJ▲ Buy—
BDJ▼ Sell$10K
BGY▲ Buy—
BGY▼ Sell$13K
BSTZ▲ Buy—
BSTZ▼ Sell$3K
CII▼ Sell$8K
CII▲ Buy—
BME▲ Buy—
BME▼ Sell$9K
BGR▲ Buy—
BGR▼ Sell$10K
BCX▲ Buy—
BCX▼ Sell$11K
BST▲ Buy—
BST▼ Sell$11K
BUI▲ Buy—
BUI▼ Sell$10K
BGY▼ Sell$12K
BGR▲ Buy—
BGR▼ Sell$5K
BOE▲ Buy—
BOE▼ Sell$11K
BGY▲ Buy—
BGR▲ Buy—
BGY▲ Buy—
BGY▼ Sell$11K
BOE▲ Buy—
BOE▼ Sell$10K
BGR▼ Sell$9K
BGY▲ Buy—
BGY▼ Sell$7K
BOE▲ Buy—
BOE▼ Sell$7K
BGR▲ Buy—
BGR▼ Sell$6K
BOE▲ Buy—
BOE▼ Sell$5K

We use analytics to understand how market-wall is used. No personal data is sold.